ATA154489A - Feste pharmazeutische ranitidinpraeparate - Google Patents

Feste pharmazeutische ranitidinpraeparate

Info

Publication number
ATA154489A
ATA154489A AT0154489A AT154489A ATA154489A AT A154489 A ATA154489 A AT A154489A AT 0154489 A AT0154489 A AT 0154489A AT 154489 A AT154489 A AT 154489A AT A154489 A ATA154489 A AT A154489A
Authority
AT
Austria
Prior art keywords
ranitidine
preparations
solid pharmaceutical
pharmaceutical
solid
Prior art date
Application number
AT0154489A
Other languages
English (en)
Other versions
AT396426B (de
Original Assignee
Glaxo Societe Anonyme Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Societe Anonyme Lab filed Critical Glaxo Societe Anonyme Lab
Publication of ATA154489A publication Critical patent/ATA154489A/de
Application granted granted Critical
Publication of AT396426B publication Critical patent/AT396426B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0154489A 1988-06-24 1989-06-23 Feste pharmazeutische ranitidinpräparate AT396426B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8808497A FR2633181B1 (fr) 1988-06-24 1988-06-24 Composition pharmaceutique a base de ranitidine et son procede de preparation

Publications (2)

Publication Number Publication Date
ATA154489A true ATA154489A (de) 1993-01-15
AT396426B AT396426B (de) 1993-09-27

Family

ID=9367671

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0154489A AT396426B (de) 1988-06-24 1989-06-23 Feste pharmazeutische ranitidinpräparate

Country Status (32)

Country Link
US (1) US5102665A (de)
JP (1) JPH0786086B2 (de)
KR (1) KR940002662B1 (de)
AT (1) AT396426B (de)
AU (1) AU627194B2 (de)
BE (1) BE1005691A4 (de)
CA (1) CA1329130C (de)
CH (1) CH679276A5 (de)
CY (1) CY1637A (de)
CZ (1) CZ280886B6 (de)
DE (1) DE3920626C2 (de)
DK (1) DK170223B1 (de)
ES (1) ES2015717A6 (de)
FR (1) FR2633181B1 (de)
GB (1) GB2219940B (de)
HK (1) HK33192A (de)
HU (1) HU210067A9 (de)
IE (1) IE60725B1 (de)
IL (1) IL90731A (de)
IT (1) IT1232149B (de)
LU (1) LU87541A1 (de)
MY (1) MY106412A (de)
NL (1) NL8901596A (de)
NZ (1) NZ229698A (de)
PH (1) PH26018A (de)
PT (1) PT90962B (de)
SA (1) SA90100095B1 (de)
SE (1) SE502285C2 (de)
SG (1) SG21892G (de)
SK (1) SK278823B6 (de)
ZA (1) ZA894787B (de)
ZW (1) ZW7889A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2636532B1 (fr) * 1988-09-20 1993-11-19 Glaxo Group Ltd Compositions pharmaceutiques
DE4027927A1 (de) * 1990-09-04 1992-03-05 Bayer Ag Brausekomponente und verfahren zu ihrer herstellung
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
US5629013A (en) * 1991-04-04 1997-05-13 The Procter & Gamble Company Chewable calcium carbonate antacid tablet compositions
FR2700669B1 (fr) * 1993-01-22 1995-04-14 Tassoni Jean Pierre Composition effervescente pour la préparation de boissons gazeuses.
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
IL112779A (en) * 1994-03-01 1999-11-30 Gergely Gerhard Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
DE69726879T2 (de) * 1996-05-17 2004-10-14 Merck & Co., Inc. Biphosphonat-formulierung mit brausewirkung
US5728401A (en) * 1997-04-16 1998-03-17 Ranbaxy Laboratories, Ltd. Effervescent ranitidine formulations
HUP9701293A3 (en) * 1997-07-25 1999-08-30 Chinoin Gyogyszer Es Vegyeszet New salts without unsavoury taste and pharmaceutical compositions containing them
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6264984B1 (en) 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
JP2001253826A (ja) * 2000-03-09 2001-09-18 Maruzen Pharmaceut Co Ltd 内服用剤
WO2002089823A1 (fr) * 2001-04-27 2002-11-14 Kyoto Pharmaceutical Industries, Ltd. Methode de conservation pour un suppositoire
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
WO2004041244A2 (en) * 2002-10-30 2004-05-21 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
US7858121B2 (en) * 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
CA2548915C (en) * 2003-12-31 2012-10-16 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
AU2004311879B2 (en) * 2003-12-31 2010-08-05 Phoenix Labs Unlimited Company Effervescent oral opiate dosage form
WO2005115345A1 (en) * 2004-05-28 2005-12-08 Imaginot Pty Ltd Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
EP3263117A1 (de) * 2005-11-28 2018-01-03 Imaginot Pty Ltd. Abgabesystem für eine orale therapeutische verbindung
WO2009008895A1 (en) * 2007-07-09 2009-01-15 Cypress Pharmaceutical, Inc. Pleasant-tasting ranitidine formulation
KR20170003414A (ko) * 2015-06-30 2017-01-09 (주)아모레퍼시픽 속붕해형 과립환 모발 세정용 조성물
CN105997922A (zh) * 2016-06-12 2016-10-12 佛山市腾瑞医药科技有限公司 一种盐酸雷尼替丁泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1962791A1 (de) * 1969-12-15 1971-06-24 Boehringer Mannheim Gmbh Brausetabletten,Brausepulver und Verfahren zur Herstellung derselben
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
PH26018A (en) 1992-01-29
SE8902288D0 (sv) 1989-06-22
IT1232149B (it) 1992-01-25
HK33192A (en) 1992-05-15
CZ280886B6 (cs) 1996-04-17
KR940002662B1 (ko) 1994-03-28
SE502285C2 (sv) 1995-09-25
GB2219940A (en) 1989-12-28
GB8914428D0 (en) 1989-08-09
ZA894787B (en) 1990-03-28
AU627194B2 (en) 1992-08-20
JPH0245421A (ja) 1990-02-15
MY106412A (en) 1995-05-30
SE8902288L (sv) 1989-12-25
FR2633181B1 (fr) 1992-01-10
DK314089A (da) 1989-12-25
GB2219940B (en) 1992-01-02
IE892047L (en) 1989-12-24
NL8901596A (nl) 1990-01-16
PT90962A (pt) 1989-12-29
BE1005691A4 (fr) 1993-12-21
IT8948116A0 (it) 1989-06-22
CY1637A (en) 1992-11-06
KR910000100A (ko) 1991-01-29
SG21892G (en) 1992-04-16
ZW7889A1 (en) 1990-02-21
SA90100095B1 (ar) 1999-06-30
DE3920626C2 (de) 1994-12-22
LU87541A1 (fr) 1990-02-28
ES2015717A6 (es) 1990-09-01
IL90731A0 (en) 1990-01-18
DK170223B1 (da) 1995-07-03
FR2633181A1 (fr) 1989-12-29
AT396426B (de) 1993-09-27
HU210067A9 (en) 1995-02-28
CZ403891A3 (en) 1993-08-11
CH679276A5 (de) 1992-01-31
IE60725B1 (en) 1994-08-10
AU3674489A (en) 1990-01-04
NZ229698A (en) 1991-05-28
PT90962B (pt) 1994-12-30
CA1329130C (en) 1994-05-03
JPH0786086B2 (ja) 1995-09-20
US5102665A (en) 1992-04-07
DE3920626A1 (de) 1989-12-28
SK403891A3 (en) 1998-03-04
SK278823B6 (sk) 1998-03-04
DK314089D0 (da) 1989-06-23
IL90731A (en) 1994-04-12

Similar Documents

Publication Publication Date Title
ATA154489A (de) Feste pharmazeutische ranitidinpraeparate
DK481989D0 (da) Farmaceutiske formuleringer
DE10199066I1 (de) Pharmazeutische Zusammensetzung
FI894611A7 (fi) Rakeisia farmaseuttisia valmisteita
NO922005D0 (no) Farmasoeytiske preparater
DK362189A (da) Farmaceutisk praeparat til intravenoes indgift
DK489189D0 (da) Farmaceutisk praeparat
DK229489D0 (da) Laegemiddeladsorbater
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
IT1232677B (it) Composizione farmaceutica contenente ranitidina
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
FI913100A7 (fi) Farmaseuttiset valmisteet
DE3682960D1 (de) Pharmazeutische praeparate.
DE3576118D1 (de) Pharmazeutische praeparate.
ATA327387A (de) Pharmazeutisches ranitidinpraeparat
DK603988D0 (da) Farmaceutisk praeparat
DK496889D0 (da) Peptidholdigt farmaceutisk praeparat
DK336489A (da) Farmaceutisk praeparat
DE68915203D1 (de) Pharmazeutische Mischungen.
ATA321188A (de) Pharmazeutische zubereitung
BR9006025A (pt) Preparacao farmaceutica
ATA133288A (de) Pharmazeutische zusammensetzung
DK37589A (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
PT85350A (de) Xylometazolinhaltige pharmazeutische praeparate
DK638889A (da) Farmaceutisk kombinationspraeparat

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee
ELA Expired due to lapse of time